A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma (Q33374572)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma |
scientific article |
Statements
1 reference
A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma (English)
1 reference
James R Berenson
1 reference
Jeffrey Matous
1 reference
Regina A Swift
1 reference
Russell Mapes
1 reference
Blake Morrison
1 reference
Howard S Yeh
1 reference
1 March 2007
1 reference
1 reference
13
1 reference
1762-1768
1 reference
Identifiers
1 reference
1 reference